Shen TH, Aby ES, Vock D, Farley JF, et al. Sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors on major liver outcomes in metabolic dysfunction-associated steatotic liver disease. Diabetes Obes Metab 2024;26:5116-5125.
PMID: 39134463